Select Page
Sylvie Ramboz, Ph.D.

Sylvie Ramboz, Ph.D.

Dr. Sylvie Ramboz received her Ph.D. in Neuropharamacology at the Institute for Genetics and Cellular and Molecular Biology, Strasbourg, France. She has extensive experience in the biotechnology industry, first at Memory Pharmaceuticals, then at Xenogen Biosciences...
Afshin Ghavami, Ph.D.

Afshin Ghavami, Ph.D.

Dr. Ghavami joined PsychoGenics in 2007 and directs molecular biology and electrophysiology groups and has been extensively involved in drug discovery research. Dr. Ghavami obtained his Ph.D. in Neuroscience, from Universite de Louis Pasteur in Strasbourg, France, in...
Stephen Morairty, Ph.D.

Stephen Morairty, Ph.D.

Dr. Stephen Morairty has over 30 years of experience in research and drug development focusing on translational neuroscience and EEG biomarkers. He received his Ph.D. in Neuroscience from UCLA and following his post-doctoral training in the Department of Psychiatry at...
Leslie Street, Ph.D.

Leslie Street, Ph.D.

Dr Street received his PhD in organic chemistry from the University of Leeds in the UK and then did postdoctoral studies, in synthetic organic chemistry, at the University of California, Los Angeles. Leslie joined Psychogenics in March 2020 as Vice President, Head of...
Christina Leahy

Christina Leahy

Christina Leahy has more than 35 years of experience in the pharmaceutical and biotechnology industries, the last 20 years with PsychoGenics Inc. As PsychoGenics Quality Assurance lead Ms. Leahy has extensive knowledge of Federal and State regulatory and compliancy...